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Abstract 
Background: Cerebral sinus venous thrombosis (CSVT) is a fatal condition and should be considered in all 
patients with acute new onset headache. D-dimer has been shown to be a sensitive diagnostic tool in deep vein 
thrombosis and pulmonary thromboembolism. The purpose of this study was to investigate whether this test could 
be useful in the diagnosis of CSVT. Materials and Methods: In this prospective study, we reviewed patients 
referring to Nemazee hospital with presentations suggestive of CSVT. Diagnosis was established, using MRI and 
MRV. Serum D-dimer level was checked among 24 hours after hospital admission. Results: From 117 enrolled 
patients, 37 (31.6%) patients had CSVT. The reported D-dimer levels showed negative (< 500 ng/ml) in 21 
(56.76%) and positive level in 16 (43.24 %) patients who had CSVT. Also, D-dimer was negative in 66 (82.5%) 
and positive in 14 (17.5%) patients who did not have CSVT. These results demonstrated a sensitivity of 43.24%, 
specificity of 82.5%, positive predictive value of 53.3%, and negative predictive value of 75.86%.  Conclusion: 
Our study suggests that D-dimer test may guide us to approach patients who are suspected with CSVT in 
emergency situations with limited access to MRI/MRV, although every patient with high D-dimer level and clinical 
suspicion of CSVT should undergo specific brain imagines. In addition, our results showed a negative D-dimer test 
was not a reliable assay to completely rule out CSVT. However, we recommend further studies to confirm our 
results.  
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Introduction 
Cerebral sinus venous thrombosis (CSVT) is a 
fatal condition accounting for 0.5 percent of all 
strokes, which leads to elevation in intracranial 
pressure and subsequent neurological disability that 
presents with variable signs and symptoms: 
headache, seizure, hemiparesis, altered 
consciousness, and papilledema (1). It was first 
reported in 1825, a rare cause of stroke especially 
among young adults and children with more 
incidences in women due to sex-related risk factors: 
oral contraceptives (OCP), pregnancy or puerperium 
and hormonal replacement therapy.  
            CSVT is one of the important differential 
diagnoses in patients with acute new onset headache 
that presents with a wide range of neurological 
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features which makes hardships in recognition; so, it 
should be considered in emergency situations to 
make the next steps in clinical approach (1). 
           Magnetic resonance imaging (MRI), magnetic 
resonance venography (MRV) and CT venography 
are routine non-invasive diagnostic approach (2). But 
due to higher incidence in developing countries and 
less access to neuroimaging techniques, an available 
and  non-expensive diagnostic method to rule out this 
disease is needed especially in emergency terms (3). 
A good choice is D-dimer blood test, a product of 
fibrin degradation which is helpful in diagnosis of 
pulmonary embolism (PE) and deep venous 
thrombosis (DVT), however, the usefulness of this 
measurement in excluding CSVT is not clear yet (4). 
Many studies have been done on the role of D-dimer 
in the diagnosis of CSVT.Although ,the negative 
predictive value of the D-dimer test in values  less 
than 500 ng/ml has been demonstrated in most of 
conducted studies , there is still a great deal of 
controversy about this. Most studies show an 
increase in serum D-dimer levels in patients with 
CSVT  compared to controls, but for the mean D-
dimer level, patients with CSVT have different 
values (5-7). In order to test D-dimer, the results of 
different laboratory methods such as ELISA, VIDAS 
and STA-Lia test did not show any significant 
difference (8). Thus, the difference in mean D-dimer 
level may be due to ethnic and regional differences. 
Due to the low prevalence of CSVT in their 
geographic area and, consequently, the low sample 
size, and retrospective study pattern, most CSVT 
studies have limited research implementation. Hence, 
they recommend prospective studies with a larger 
sample size (5, 7, 9, 10). 
            In this prospective study, we considered the 
role of D-dimer in diagnose of CSVT in comparison 
with MRI/MRV in  Nemazee Hospital referred 
patents with notable incidence of CSVT and larger 
sample size. Indeed, in spite of most recent studies 
which were done retrospectively on the documented 
cases of CSVT, our study was designed prospectively 
on all patients who are suspicious to CSVT aside 
they are had the disease or not. Therefore, we could 
determine sensitivity, specificity, positive and negative 
predictive value of the D-dimer test.    
Methods 
Patients. In this prospective study, we 
reviewed all consecutive adult patients referring to 
the emergency department of Nemazee Hospital, an 
academic center affiliated to Shiraz University of 
Medical Sciences, from December 2015 to December 
2017 with new onset headache and presentations 
suggestive of CSVT. Every medical or surgical 
condition which causes an increase in D-dimer level 
was considered as exclusion criteria. 
Computed Tomography (CT) scan was 
performed in all suspected cases of CSVT. The 
diagnosis was established using MRI (1.5 TESLA) 
and MRV(Three-dimensional time of flight (3D-
TOFL)). Serum D-dimer level was checked at time 
of the patients admission and before starting 
anticoagulant therapy  if they had CSVT; using a 
turbidimetric method with a normal reference range 
below 500 ng/ml.. If the quantitative result was less 
than 500 ng/ml, it was considered as negative and 
equal or more than that was noted positive test. 
Written consent was obtained before entering the 
study. For all subjects, a neurological examination, 
including evaluation of mental status, motor 
function, sensory modalities, cranial nerves, and 
ophthalmoscopy, was done by a neurologist and a 
questionnaire was filled out anonymously for each 
person (demographic data, gender, age, risk factor). 
The data were logged into the SPSS software and 
analyzed by a statistician. Descriptive data were 
shown as mean ± standard deviation. Independent 
student T test or Chi square tests were used for data 
analysis as appropriate. After determination of 
patients with real diagnosis of CSVT and results of 
the D-dimer tests, sensitivity, specificity, negative 
and positive predictive values were calculated. Cut-
off point was also evaluated by ROC cure analysis. A 
p value <0.05 was applied to interpret all achieved 
data from analysis. This study was reviewed and 
approved by Ethics Committee of Shiraz University 
of Medical Sciences with a grant number 95-01-94-
11609. 
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Results 
In this observational cross-sectional study, 
we enrolled 117 patients (27 men, 90 women). 37 
(31.6%) patients were CSVT positive and 80 were 
CSVT negative. Patients with negative results of 
MRI/MRV included 62 females and 18 males; 
whereas positive results were found in 27 females 
and 10 males. The mean age was 37.72 ± 12.256 
years in the negative and 37.49 ± 10.471 in the 
positive group. The results are shown in Table 1. 
From eight  evaluated pregnant women, none had 
CSVT (p =0.04). 
 
          Table1. Demographic and clinical data of all patients 
     Patients   
characteristics 
      (n=117) 
CSVT                                   
    
          Yes                       No 
       (n=37)                (n=80) 
 
       P 
value 
Age (mean ±SD)  37.49±10.471 37.72±12.256 0.97 
Sex (Female)  27 (30.0%) 63(70.0%) 0.36 
OCP 
consumption 
 16(43.2%) 20(24.7%)         0.03 
Pregnancy  0 (0.0%) 8 (9.9%)         0.04 
Postpartum  5 (13.5%) 8 (9.9%)         0.38 
Protein C or S 
deficiency 
 0 (0.0%) 1 (2.7%)         0.31 
Previous DVT  3 (8.1%) 2 (2.5%)         0.17 
Neurological 
manifestations 
   
Papilledema  1 (2.7%) 2 (2.5%)         0.68 
Seizure  9 (24.3%) 8 (9.9%)         0.04 
Limb weakness  7 (18.9%) 18 (22.2%)         0.44 
Impaired Level 
of  
Consciousness 
 4 (10.8%) 5 (6.2%)         0.29 
Laboratory data    
ESR (mean ± 
SD) 
25.536±20.5 23.421±22.3793        0.383 
WBC (95% CI) 10.57 (8.0914.66) 9.89 (8.37-11.95)        0.72 
 SD: standard deviation. CI: confidence interval. 
 
         The reported d-dimer levels of both groups are 
shown in Table 2. According to D-dimer results, the 
cut-off point of 500 ng/ml was determined. For cut-
off point 0.5, Area Under the Curve (AUC) was 
0.645 (p= 0.008). Accordingly, this level of value 
had acceptable ability to recognize the CSVT. The 
results yielded a sensitivity of 43.24%, specificity of 
82.5%, positive predictive value of 53.3% and 
negative predictive value of 75.86% (Figure 1).  
 
 
 
 
Table 2. D-dimer values in patients with and without CVT 
D-dimer value 
(ng/ml) 
   With CSVT  
Number (%) 
Without CSVT 
Number (%) 
P value 
Positive ( >500 
ng/ml) 
16(43.24 %) 14(17.5%) 24 
25.10 
Negative (<500 
ng/ml) 
21(56.76%) 66(82.5%) 
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Figure 1: Comparison of the under curve surface for D-dimer 
 
Discussion 
          Degradation of fibrin in the blood causes D-
dimer elevation which is used in evaluating the 
amount of thrombin and plasmin production in blood 
circulation and has been considered as a long half-life , 
an easy, non- expensive and  available diagnostic 
marker in thrombotic events (11). D-dimer test is 
helpful in excluding deep vein thromboembolism and 
pulmonary thromboembolism (5). Moreover, several 
studies have indicated that D-dimer is a beneficial 
diagnostic tool in patients suspicious with cerebral 
sinus vein thrombosis (3-5, 7, 12-15). The cut off 
value of 500 ng/ml is usually defined in thrombotic 
events and also CSVT as we used here.  
0.003 
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         In our study, the D-dimer level was positive 
only in 43.24% of 37 CSVT positive patients. This 
shows D-dimer is not a sensitive tool for diagnosing 
cerebral sinus vein thrombosis, so a normal D-dimer 
level in our study could not exclude CSVT in 
patients with symptoms suggested disease. In a 
similar study conducted on 73 patients with positive 
CSVT, normal D-dimer levels were found in 7 
patients (10%) (16). In a study done in Egypt, D-
dimer value more than 500 ng/ml was reported in 
85.7% (18 of 23) of CVST positive patients (5). 
Also, in another prospective study with 343 patients, 
a positive D-dimer level (defined as a level >500 
ng/mL) was found in 34 of 35 CSVT positive 
patients and 27 of 308 patients without CVT. This 
result produced a sensitivity of 97.1%, which 
confirms a clinically helpful role of D-dimer in 
diagnosing CSVT (13). According to American 
Heart Association/American Stroke Association a 
normal D-dimer level may be considered to help 
identify the patients with low probability of CSVT, 
but if there is a strong clinical suspicion of CSVT, a 
normal D-dimer level should not preclude further 
evaluation (17). Our results showed that the D-dimer 
was negative (< 500 ng/ml) in 66 out of 80 patients 
who did not have CSVT. This means that D-dimer 
test has a negative predictive value of 75.86%; thus, 
a value under 500 ng/mL makes presence of CSVT 
unusual, similar to some recent studies. Kosinski 
reported a higher negative predictive value of 99.6% 
in favor of having no CSVT when D-dimers were 
negative (< 500 ng/ml). It suggested that if duration 
of symptoms is more than 2 weeks, normal d-dimer 
is not useful for exclusion of CSVT (13). 
No pregnant women had CSVT. We think that  it 
could be related to  low threshold of our emergency 
staff and physicians to prove the disease in this group 
of patients as soon as possible. Hence, they may 
evaluate them more than the others. 
          According to our findings, D-dimer specificity 
is 82.5%, in cases referred to the emergency 
department with neurological symptoms. It pointed 
into notion that   this test is a good diagnostic tool for 
the detection of CSVT because of its high specificity. 
On the other hand, when there is a suspicion of 
thrombosis in the central nervous system, positive 
result could be more helpful.  Whereas, peripheral 
thrombosis (deep vein thrombosis and pulmonary 
embolism) in which sensitivity of D-dimer is high, 
negative result seems to be more useful. We think this 
difference in sensitivity and specificity of D-dimer in 
central and peripheral parts of the body may be due to 
many causes for elevated D-dimer in the periphery and 
out of central nervous system (17), but in the central 
portion of the body there are not so heterogenic 
causes. 
          In agreement with our findings,   Alons et al. in 
2015 reported a high D-dimer specificity (84.9%) with 
636 consecutive patients (4).In other study,  Meng et 
al. found a specificity of  97.5% with 233 patients and 
they suggested that using D-dimer as a screening 
approach is a good way to define which patients are 
candidates for urgent MRI/MRV (14). Therefore, D-
dimer value seems to be helpful for ruling out CSVT 
in patients presenting with acute headache in 
emergency situation, especially in developing 
countries that have limited access to expensive 
diagnostic tools like MRI/MRV. Although previous 
studies confirmed the utility of D-dimer marker in 
diagnosing patients without CSVT, they recommended 
that it was not a reliable assay to completely exclude 
CSVT, particularly in patients with recent isolated 
headache (5, 16).  
       We found 21 out of 37 CSVT positive patients 
with negative D-dimer.  Multiple factors may account 
for these false negative results. First, D-dimer values 
reduce with time from the onset of symptoms, which 
indicated that patients who have subacute or chronic 
features were more prone to have normal d-dimer 
levels. Second, the level of CSVT involvement may 
correlate with D-dimer levels, which suggests that 
patients with lesser clot spread may have false 
negative D-dimer test results. Finally, several assays 
are available to measure the blood levels of D-dimer 
with variable test performance (13, 17). 
         In conclusion, the sensitivity of D-dimer marker 
was 43.24% and its specificity was 82.5% in this 
study. Therefore, it seems that a negative D-dimer test 
is a good clinical tool because it makes cerebral sinus 
vein thrombosis unlikely to happen.   
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 Conclusion 
Our study suggests that D-dimer test may guide us to 
approach patients who are suspected with CSVT in 
emergency situations with limited access to 
MRI/MRV, although every patient with high D-
dimer level and clinical suspicion of CSVT should 
also undergo specific brain imagines. 
          In addition, our results showed a negative D-
dimer test was not a reliable assay to completely rule 
out CSVT. However, we recommend further studies 
with larger number of patients to confirm our results.  
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